PRE B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

Clinical trials for PRE B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA explained in plain language.

Never miss a new study

Get alerted when new PRE B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA trials appear

Sign up with your email to follow new studies for PRE B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to stop cancer return after transplant

Disease control Ongoing

This study tests a drug called blinatumomab given after a stem cell transplant to help prevent relapse in people with B-cell acute lymphoblastic leukemia or B-cell non-Hodgkin lymphoma. About 44 participants will receive the drug as maintenance therapy. The goal is to see if it i…

Matched conditions: PRE B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated Jun 15, 2026 18:54 UTC

PRE B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

Get alerted when new PRE B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA trials appear

New drug combo aims to stop cancer return after transplant